P-Glycoprotein, Breast Cancer Resistance Protein, Organic Anion Transporter 3, and Transporting Peptide 1a4 during Blood–Brain Barrier Maturation: Involvement of Wnt/β-Catenin and Endothelin-1 Signaling

Organic Anion ◽

Organic Anion Transporter ◽

Cancer Resistance ◽

P Glycoprotein ◽

Anion Transporter ◽

Resistance Protein ◽

Organic Anion Transporter 3

Influence of breast cancer resistance protein (Abcg2) and p-glycoprotein (Abcb1a) on the transport of imatinib mesylate (Gleevec®) across the mouse blood-brain barrier

Journal of Neurochemistry ◽

10.1111/j.1471-4159.2007.04808.x ◽

2007 ◽

Vol 102 (6) ◽

pp. 1749-1757 ◽

Cited By ~ 62

Author(s):

Sébastien Bihorel ◽

Gian Camenisch ◽

Michel Lemaire ◽

Jean-Michel Scherrmann

Keyword(s):

Breast Cancer ◽

Imatinib Mesylate ◽

Blood Brain Barrier ◽

Brain Barrier ◽

Cancer Resistance ◽

Mouse Blood ◽

P Glycoprotein ◽

Blood Brain ◽

Insight into the Cooperation of P-glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) at the Blood–Brain Barrier: A Case Study Examining Sorafenib Efflux Clearance

Molecular Pharmaceutics ◽

10.1021/mp200465c ◽

2012 ◽

Vol 9 (3) ◽

pp. 678-684 ◽

Cited By ~ 43

Author(s):

Sagar Agarwal ◽

William F. Elmquist

Keyword(s):

Breast Cancer ◽

Blood Brain Barrier ◽

Brain Barrier ◽

Cancer Resistance ◽

P Glycoprotein ◽

Blood Brain ◽

Resistance Protein ◽

Insight Into

Interaction of 11C-Tariquidar and 11C-Elacridar with P-Glycoprotein and Breast Cancer Resistance Protein at the Human Blood-Brain Barrier

Journal of Nuclear Medicine ◽

10.2967/jnumed.112.118232 ◽

2013 ◽

Vol 54 (8) ◽

pp. 1181-1187 ◽

Cited By ~ 36

Author(s):

M. Bauer ◽

R. Karch ◽

M. Zeitlinger ◽

J. Stanek ◽

C. Philippe ◽

...

Keyword(s):

Breast Cancer ◽

Blood Brain Barrier ◽

Human Blood ◽

Brain Barrier ◽

Cancer Resistance ◽

P Glycoprotein ◽

Blood Brain ◽

Susceptibility of juvenile and adult blood–brain barrier to endothelin-1: regulation of P-glycoprotein and breast cancer resistance protein expression and transport activity

Journal of Neuroinflammation ◽

10.1186/1742-2094-9-273 ◽

2012 ◽

Vol 9 (1) ◽

Cited By ~ 13

Author(s):

Rania Harati ◽

Anne-Sophie Villégier ◽

William A Banks ◽

Aloise Mabondzo

Keyword(s):

Breast Cancer ◽

Protein Expression ◽

Blood Brain Barrier ◽

Brain Barrier ◽

Cancer Resistance ◽

Transport Activity ◽

Endothelin 1 ◽

P Glycoprotein ◽

[18F]FDG is not transported by P-glycoprotein and breast cancer resistance protein at the rodent blood–brain barrier

Nuclear Medicine and Biology ◽

10.1016/j.nucmedbio.2015.03.004 ◽

2015 ◽

Vol 42 (7) ◽

pp. 585-589 ◽

Cited By ~ 2

Author(s):

Thomas Wanek ◽

Alexander Traxl ◽

Jens P. Bankstahl ◽

Marion Bankstahl ◽

Michael Sauberer ◽

...

Keyword(s):

Breast Cancer ◽

Blood Brain Barrier ◽

Brain Barrier ◽

Cancer Resistance ◽

P Glycoprotein ◽

Blood Brain ◽

Resistance Protein ◽

18F Fdg

Double-Transduced MDCKII Cells To Study Human P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) Interplay in Drug Transport across the Blood−Brain Barrier

Molecular Pharmaceutics ◽

10.1021/mp1003898 ◽

2011 ◽

Vol 8 (2) ◽

pp. 571-582 ◽

Cited By ~ 47

Author(s):

Birk Poller ◽

Els Wagenaar ◽

Seng Chuan Tang ◽

Alfred H. Schinkel

Keyword(s):

Breast Cancer ◽

Blood Brain Barrier ◽

Drug Transport ◽

Brain Barrier ◽

Cancer Resistance ◽

P Glycoprotein ◽

Blood Brain ◽

Mdckii Cells ◽

Effect of GenX on P-Glycoprotein, Breast Cancer Resistance Protein, and Multidrug Resistance–Associated Protein 2 at the Blood–Brain Barrier

Environmental Health Perspectives ◽

10.1289/ehp5884 ◽

2020 ◽

Vol 128 (3) ◽

pp. 037002 ◽

Cited By ~ 1

Author(s):

Ronald E. Cannon ◽

Alicia C. Richards ◽

Andrew W. Trexler ◽

Christopher T. Juberg ◽

Birandra Sinha ◽

...

Keyword(s):

Breast Cancer ◽

Multidrug Resistance ◽

Blood Brain Barrier ◽

Brain Barrier ◽

Cancer Resistance ◽

P Glycoprotein ◽

Blood Brain ◽

Faculty Opinions recommendation of Distribution of gefitinib to the brain is limited by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2)-mediated active efflux.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.3171959.2859057 ◽

2010 ◽

Author(s):

Susan Bates

Keyword(s):

Breast Cancer ◽

Cancer Resistance ◽

Active Efflux ◽

P Glycoprotein ◽

Resistance Protein ◽

The Brain

Faculty Opinions recommendation of Brain accumulation of the EML4-ALK inhibitor ceritinib is restricted by P-glycoprotein (P-GP/ABCB1) and breast cancer resistance protein (BCRP/ABCG2).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725783242.793517907 ◽

2016 ◽

Author(s):

Susan Bates

Keyword(s):

Breast Cancer ◽

Cancer Resistance ◽

Glycoprotein P ◽

Alk Inhibitor ◽

P Glycoprotein ◽

Faculty of 1000 evaluation for The "specific" P-glycoprotein inhibitor tariquidar is also a substrate and an inhibitor for breast cancer resistance protein (BCRP/ABCG2).

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.9419956.10057054 ◽

2011 ◽

Author(s):

Robert Fecik

Keyword(s):

Breast Cancer ◽

Cancer Resistance ◽

P Glycoprotein ◽